ST. PETERSBURG, FL / ACCESSWIRE / December 13, 2017 / Consilium Global Research (CGR) an Investor Recognition Company that connects Companies with Investors, today announced that it has issued an Initiation of Coverage Research Report on Zynex Inc. (OTCQB: ZYXI).
The Comprehensive Research Report is available here:
http://www.consiliumglobalresearch.com/PDF/12052017-119_ZYXI_report.pdf
The Research Report has several segments: Company Overview, Investment Thesis, Industry Overview, Comparable Analysis, Valuation, Catalysts, Financial Highlights and Models.
About Zynex Inc.
Zynex is the leading provider of Electrotherapy Medical Devices used for pain management and rehabilitation. The company is also pioneering development of an Innovative Blood Volume Monitor.
The company is segmented into Zynex Medical, Inc. and Zynex Monitoring Solutions. Under the leadership of Thomas Sandgaard (Founder, Chairman, President and CEO), ZYXI has managed to create a synergistic model between the two segments resulting in a company growing faster than its underlying market, often referred to as a hybrid or best of breed. We believe ZYXI will be able to continue to grow faster and more consistently than the underlying markets it serves.
The Investment Thesis is based upon:
An Impressive Turnaround with a major Paradigm Shift Continued Sales Growth and Profit Margin Expansion Driven by:
- An Improved Reimbursement Strategy
- Expansion of the Salesforce
- An Increase in higher margin Consumables
- Exit of a major competitor
- New Products and Markets
The Possible 510 (K) FDA Clearance for the CM 1500A first to market Blood Monitoring Device addressing a potential $3B market.
Continued EBITDA Expansion.
The planned up listing to the NYSE American or the NASDAQ CM.
About Consilium Global Research
Consilium Global Research (CGR) is an Investor Recognition Company that provides Research and Strategic Advisory Services to help public companies raise their profile in the investment community. The CGR business model is built upon four mutually - reinforced pillars.
- Insightful Wall Street Research Coverage - Research that formulates an equity story that will resonate with the investment community (institutional and retail).
- The Broadest Research Distribution Platform- addresses the Institutional and Retail Investment Community
- A Corporate Access Program - meeting with key decision makers at major institutions and high net worth retail groups.
- Strategic Advisory - identifies problems and delivers custom solutions.
The CGR Business Plan is executed by a highly respected professional team known for their integrity and results oriented approach. The end result is a broader investor base (institutional and retail), increased trading activity and subsequently lower cost of capital
Consilium Global Research bridges the gap between public companies and the investment community.
For more information, visit www.ConsiliumGlobalResearch.com
Forward-Looking Statements
The content of this report has been compiled primarily from information available to the public released by the Company. The Company is solely responsible for the accuracy of that information.
We do not recommend or solicit an investment in any particular stock or other security. We have prepared our research based upon information and sources considered to be reliable.
The opinions expressed in this report are the true opinions of the analyst about this company and industry. Some of the information in this research report relates to future events or future business and financial performance. Such statements constitute forward-looking information within the meaning of the Private Securities Litigation Act of 1995. Any "forward-looking statements" are our best estimates and opinions based upon information that is publicly available and that we believe to be correct, but we have not independently verified with respect to truth or correctness. There is no guarantee that our forecasts will materialize. Actual results will likely vary.
Contact Information
Consilium Global Research
360 Central Ave, Suite 800
St. Petersburg, FL 33701
www.ConsiliumGlobalResearch.com
info@ConsiliumGlobalResearch.com
Zynex Medical, Inc.
10000 Park Meadows Drive
Lone Tree, CO 80124
(800) 495-6670
www.zynexmed.com
info@zynex.com
SOURCE: Consilium Global Research
